Open AccessHDAC inhibitor chidamide synergizes with venetoclax to inhibit the growth of diffuse large B-cell lymphoma via down-regulation of MYC, BCL2, and TP53 expression
Author(s) -
Cancan Luo,
Tiantian Yu,
Ken H. Young,
Li Yu
Publication year - 2022
Publication title -
journal of zhejiang university science b
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.624
H-Index - 56
eISSN - 1862-1783
pISSN - 1673-1581
DOI - 10.1631/jzus.b2200016
Subject(s) - venetoclax , cancer research , diffuse large b cell lymphoma , lymphoma , apoptosis , histone deacetylase inhibitor , oncogene , cell cycle , histone deacetylase , in vivo , biology , chemistry , histone , immunology , leukemia , chronic lymphocytic leukemia , gene , biochemistry , microbiology and biotechnology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom